Last month brought news that an inexpensive generic drug is remarkably effective in reducing congestive...
Contributor Information
Daniel E. Troy
Managing Director, Berkeley Research Group
Biography
Dan Troy is Managing Director and an expert witness on FDA matters at Berkeley Research Group. Previously he served as Chief Counsel of the US Food and Drug Administration and General Counsel of GlaxoSmithKline PLC.
FDA Censorship Could Cost Lives
Daniel E. Troy
Last month brought news that an inexpensive generic drug is remarkably effective in reducing congestive...